Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
about
Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsFull Length Interleukin 33 Aggravates Radiation-Induced Skin Reaction.A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.The oncolytic peptide LTX-315 triggers necrotic cell death.Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in MiceContribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells.A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency.Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.Relevance of necroptosis in cancer.Necroptosis: Mechanisms and Relevance to Disease.Reassessing the role of NAD as a prosurvival factor.The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermiaDual Function of Gold Nanoparticles in Synergism with Mitoxantrone and Microwave Hyperthermia Against Melanoma CellsImmunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity.Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.
P2860
Q28552235-3ADCC21B-FE36-4488-BB54-70A9EA89FA71Q33843062-A8239D4A-2BB9-4C2D-8BF2-B8E995320035Q33889409-85763E89-3714-406C-AC6D-4662400F2192Q36780793-5E0C2AB4-04D2-4283-9B9D-DD7BF4577DDBQ37008807-FDAA820C-A468-489E-A614-87EF95D7227BQ37078968-ECEE646E-C383-4CF9-8B61-254851E3DBB1Q37525422-F5EA8655-7B9C-4145-8FD2-FD59E725B1FEQ37536525-04CA5729-A02F-4BF4-B18C-B1083E011B57Q38605930-56A626D0-9D2C-47E4-B1E8-3994AFDF44DCQ38641806-F0905E85-61E5-410F-8D09-E667DEA5DD0FQ38804738-6A5C97D9-86D4-4D8F-AFAD-12218BA7E5BFQ39030578-67F9637D-FBA5-4BAE-B3E0-ED1B67513A60Q40411907-57FF546B-7EC4-4527-BE1B-CDF2AF348F32Q40632295-5EE783CD-A75A-4AA1-8893-BA858A194DC9Q42427640-03861270-1B37-4A78-8704-C5F6972B150FQ47317062-A01768B3-6137-46F9-8BD3-B1447E32E5A9Q48193685-AFBCDAE1-0B44-425A-A571-7C6A5A36F0A5Q51551651-258B9818-3B87-43C9-AC0A-BEBC3308BE22Q55316979-AC49A35B-2545-4F76-8DBF-8D938469C8DA
P2860
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Modulation of radiochemoimmuno ...... - and T-cell-dependent manner.
@ast
Modulation of radiochemoimmuno ...... - and T-cell-dependent manner.
@en
type
label
Modulation of radiochemoimmuno ...... - and T-cell-dependent manner.
@ast
Modulation of radiochemoimmuno ...... - and T-cell-dependent manner.
@en
prefLabel
Modulation of radiochemoimmuno ...... - and T-cell-dependent manner.
@ast
Modulation of radiochemoimmuno ...... - and T-cell-dependent manner.
@en
P2093
P2860
P356
P1476
Modulation of radiochemoimmuno ...... - and T-cell-dependent manner.
@en
P2093
N Werthmöller
R Wunderlich
P2860
P2888
P356
10.1038/CDDIS.2015.129
P577
2015-05-14T00:00:00Z
P5875
P6179
1042488874